These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24305729)

  • 61. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 62. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Solid facial edema: treatment failure with oral isotretinoin monotherapy and combination oral isotretinoin and oral steroid therapy.
    Patel AB; Harting MS; Hsu S
    Dermatol Online J; 2008 Jan; 14(1):14. PubMed ID: 18319031
    [No Abstract]   [Full Text] [Related]  

  • 64. A practical approach for the use of oral isotretinoin for infantile acne.
    Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
    Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A new rapidly absorbed paediatric paracetamol suspension. A six-way crossover pharmacokinetic study comparingthe rate and extent of paracetamol absorption from a new paracetamol suspension with two marketed paediatric formulations.
    Smith S; Collaku A; Heaslip L; Yue Y; Starkey YY; Clarke G; Kronfeld N
    Drug Dev Ind Pharm; 2012 Mar; 38(3):372-9. PubMed ID: 21961887
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
    Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
    Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Progressive macular hypomelanosis showing excellent response to oral isotretinoin.
    Kim YJ; Lee DY; Lee JY; Yoon TY
    J Dermatol; 2012 Nov; 39(11):937-8. PubMed ID: 22724575
    [No Abstract]   [Full Text] [Related]  

  • 69. Night blindness following low-dose isotretinoin.
    Halpagi P; Grigg J; Klistorner A; Damian DL
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):893-4. PubMed ID: 18031494
    [No Abstract]   [Full Text] [Related]  

  • 70. Randomised crossover studies of the bioequivalence of two fenofibrate formulations after administration of a single oral dose in healthy volunteers.
    Sonet B; Vanderbist F; Streel B; Houin G
    Arzneimittelforschung; 2002; 52(3):200-4. PubMed ID: 11963648
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Unsuccessful treatment of progressive macular hypomelanosis with oral isotretinoin.
    Damevska K; Pollozhani N; Neloska L; Duma S
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28631424
    [No Abstract]   [Full Text] [Related]  

  • 72. [Darier-White disease treated with oral isotretinoin].
    Eimer L; Lagodin C; Bonavia P; Stringa M; Rébora I; Anaya J
    Arch Argent Pediatr; 2011 Aug; 109(4):e63-6. PubMed ID: 21829859
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of refractory subacute cutaneous lupus erythematosus with oral isotretinoin: a valid therapeutic option.
    D'Erme AM; Milanesi N; Difonzo EM; Lotti T; Gola M
    Dermatol Ther; 2012; 25(3):281-2. PubMed ID: 22913448
    [No Abstract]   [Full Text] [Related]  

  • 74. Extensive and recalcitrant common warts in an immunocompetent patient: rapid and complete remission after oral isotretinoin monotherapy.
    Pasmatzi E; Badavanis G; Kapranos N; Apostolidou A; Monastirli A; Tsambaos D
    Acta Dermatovenerol Alp Pannonica Adriat; 2020 Mar; 29(1):35-37. PubMed ID: 32206821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A case of sebaceous hyperplasia maintained on low-dose isotretinoin after carbon dioxide laser treatment.
    Noh S; Shin JU; Jung JY; Lee JH
    Int J Dermatol; 2014 Feb; 53(2):e151-3. PubMed ID: 23621277
    [No Abstract]   [Full Text] [Related]  

  • 76. [Rhinophyma : Successful treatment with low-dose oral isotretinoin].
    Pohl L; Karsai S; Raulin C
    Hautarzt; 2018 Oct; 69(10):853-856. PubMed ID: 29637224
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Food increases the bioavailability of isotretinoin.
    Colburn WA; Gibson DM; Wiens RE; Hanigan JJ
    J Clin Pharmacol; 1983; 23(11-12):534-9. PubMed ID: 6582073
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A 2017 update: Challenging the cosmetic procedural delay following oral isotretinoin therapy.
    McDonald KA; Shelley AJ; Pierscianowski T; Alavi A
    J Cosmet Laser Ther; 2019; 21(1):58-60. PubMed ID: 29488816
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current challenges in bioequivalence, quality, and novel assessment technologies for topical products.
    Yacobi A; Shah VP; Bashaw ED; Benfeldt E; Davit B; Ganes D; Ghosh T; Kanfer I; Kasting GB; Katz L; Lionberger R; Lu GW; Maibach HI; Pershing LK; Rackley RJ; Raw A; Shukla CG; Thakker K; Wagner N; Zovko E; Lane ME
    Pharm Res; 2014 Apr; 31(4):837-46. PubMed ID: 24395404
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 'Washout' period for oral tetracycline antibiotics prior to systemic isotretinoin.
    Caruana DM; Wylie G
    Br J Dermatol; 2016 Apr; 174(4):929-30. PubMed ID: 26575081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.